‘We are learning from this’: After death of FMT recipient, a warning about screening

In June, the FDA issued a safety alert after two patients who had received investigational fecal microbiota transplants in two separate clinical trials developed invasive infections caused by drug-resistant Escherichia coli, and one died.In a report summarizing the two cases that was published today in The New England Journal of Medicine, researchers said the stool donor for both transplants had no risk factors that would have indicated they carried multidrug-resistant organisms, and they donated stool before the trials required testing for extended-spectrum beta-lactamase (ESBL)-producingRead More

Share on facebook
Share on twitter
Share on linkedin